This Complete Inpatient EHR is 2014 Edition compliant and has been certified by an ICSA Labs, ONC-ACB, in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

AmkaiCharts Version 3.6 was certified on 03/28/2016 CHPL Product Number: 140062R02

Additional types of costs that could be incurred by purchaser of this system include: Purchase of AmkaiOffice practice management solution, yearly support fees, medication barcode scanners, and health information exchange subscription fees.

Limitations that a user may encounter in the course of using AmkaiCharts may include that SimpleAdmit patient portal must be used to satisfy View, Download, and Transmit measure. Health information exchanges used must be willing to interface with Amkai. At this time only one HIE has been specially integrated, and that is HSX of Pennsylvania.

Required Software:

PopHealth, AmkaiOffice, Simple Admit, Meinberg NTP, MedLine Plus

Certification Standards

 

Clinical Quality Measures

 

170.314(a)(1)  COMPUTERIZED PROVIDER ORDER ENTRY CMS71  STROKE-3 ISCHEMIC STROKE – ANTICOAGULATION THERAPY FOR ATRIAL  FIBRILLATION/FLUTTER
170.314(a)(2)  DRUG-DRUG, DRUG-ALLERGY INTERACTION CHECKS CMS72  STROKE-5 ISCHEMIC STROKE – ANTITHROMBOTIC THERAPY BY END OF HOSPITAL DAY TWO
170.314(a)(3)  DEMOGRAPHICS CMS73  VTE-3 VTE PATIENTS WITH ANTICOAGULATION OVERLAPTHERAPY
170.314(a)(4)  VITAL SIGNS, BODY MASS INDEX, AND GROWTH CHARTS CMS91  STROKE-4 ISCHEMIC STROKE – THROMBOLYTIC THERAPY
170.314(a)(5)  PROBLEM LIST CMS104  STROKE-2 ISCHEMIC STROKE – DISCHARGED ON ANTI-THROMBOTIC THERAPY
170.314(a)(6)  MEDICATION LIST CMS105  STROKE-6 ISCHEMIC STROKE – DISCHARGED ON STATIN MEDICATION
170.314(a)(7)  MEDICATION ALLERGY LIST CMS107  STROKE-8 ISCHEMIC OR HEMORRHAGIC STROKE – STROKE EDUCATION
170.314(a)(8)  CLINICAL DECISION SUPPORT CMS108  VENOUS THROMBOEMBOLISM (VTE)-1 VTE PROPHYLAXIS
170.314(a)(9)  ELECTRONIC NOTES CMS109  VTE-4 VTE PATIENTS RECEIVING UNFRACTIONATED HEPARIN (UFH) WITH DOSAGES/PLATELET COUNT MONITORING BY PROTOCOL (OR NOMOGRAM)
170.314(a)(10)  DRUG-FORMULARY CHECKS CMS110  VTE-5 VTE DISCHARGE INSTRUCTIONS
170.314(a)(11)  SMOKING STATUS CMS114  VTE-6 INCIDENCE OF POTENTIALLY PREVENTABLE VTE
170.314(a)(12)  IMAGE RESULTS CMS171  SCIP-INF-1 PROPHYLACTIC ANTIBIOTIC RECEIVED WITHIN 1 HOUR PRIOR TO SURGICAL INCISION
170.314(a)(13)  FAMILY HEALTH HISTORY CMS172  SCIP-INF-2-PROPHYLACTIC ANTIBIOTIC SELECTION FOR SURGICAL PATIENTS
170.314(a)(14)  PATIENT LIST CREATION CMS178 SCIP-INF-9- URINARY CATHETER REMOVED ON POSTOPERATIVE DAY 1 (POD1) OR POSTOPERATIVE DAY 2 (POD2) WITH DAY OF SURGERY BEING DAY ZERO.
170.314(a)(15)  PATIENT-SPECIFIC EDUCATION RESOURCES CMS188  PN-6- INITIAL ANTIBIOTIC SELECTION FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) IN IMMUNOCOMPETENT PATIENTS
170.314(a)(16)  ELECTRONIC MEDICATION ADMINISTRATION RECORD CMS190  VTE-2 INTENSIVE CARE UNIT (ICU) VTE PROPHYLAXIS
170.314(a)(17)  ADVANCE DIRECTIVES
170.314(b)(1)  TRANSITIONS OF CARE – RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES
170.314(b)(2)  TRANSITIONS OF CARE – CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES
170.314(b)(3)  ELECTRONIC PRESCRIBING
170.314(b)(4)  CLINICAL INFORMATION RECONCILIATION
170.314(b)(5)  INCORPORATE LABORATORY TESTS AND VALUES/RESULTS
170.314(b)(6)  TRANSMISSION OF ELECTRONIC LABORATORY TESTS AND VALUES/RESULTS TO AMBULATORY PROVIDERS
170.314(b)(7)  DATA PORTABILITY
170.314(c)(1)  CLINICAL QUALITY MEASURES – CAPTURE AND EXPORT
170.314(c)(2)  CLINICAL QUALITY MEASURES – IMPORT AND CALCULATE
170.314(c)(3)  CLINICAL QUALITY MEASURES – ELECTRONIC SUBMISSION
170.314(d)(1)  AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION
170.314(d)(2)  AUDITABLE EVENTS AND TAMPER-RESISTANCE
170.314(d)(3)  AUDIT REPORT(S)
170.314(d)(4)  AMENDMENTS
170.314(d)(5)  AUTOMATIC LOG-OFF
170.314(d)(6)  EMERGENCY ACCESS
170.314(d)(7)  END-USER DEVICE ENCRYPTION
170.314(d)(8)  INTEGRITY
170.314(d)(9)  ACCOUNTING OF DISCLOSURES (OPTIONAL)
170.314(e)(1)  VIEW, DOWNLOAD, AND TRANSMIT TO 3RD PARTY
170.314(f)(1)  IMMUNIZATION INFORMATION
170.314(f)(2)  TRANSMISSION TO IMMUNIZATION REGISTRIES
170.314(f)(3)  TRANSMISSION TO PUBLIC HEALTH AGENCIES – SYNDROMIC SURVEILLANCE
170.314(f)(4)  TRANSMISSION OF REPORTABLE LABORATORY TESTS AND VALUES/RESULTS
170.314(g)(2)  AUTOMATED MEASURE CALCULATION
170.314(g)(3)  SAFETY-ENHANCED DESIGN
170.314(g)(4)  QUALITY MANAGEMENT SYSTEM